CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,493 | -99.9% | 769,336 | -15.4% | 0.02% | -30.4% |
| Q3 2022 | $6,096,000 | +163.8% | 909,890 | +65.8% | 0.02% | +155.6% |
| Q2 2022 | $2,311,000 | +2039.8% | 548,843 | +1618.8% | 0.01% | – |
| Q1 2022 | $108,000 | -75.8% | 31,931 | -77.5% | 0.00% | -100.0% |
| Q4 2021 | $447,000 | -42.2% | 141,964 | -39.9% | 0.00% | -50.0% |
| Q3 2021 | $773,000 | +29.3% | 236,367 | +66.8% | 0.00% | 0.0% |
| Q2 2021 | $598,000 | -4.9% | 141,686 | +12.4% | 0.00% | -33.3% |
| Q1 2021 | $629,000 | -52.2% | 126,032 | +15.0% | 0.00% | -70.0% |
| Q2 2019 | $1,315,000 | – | 109,588 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |